IDIOPATHIC INFLAMMATORY MYOPATHIES
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell therapy takes on lupus and scleroderma in early trial
Disease control OngoingThis early-stage study tests a new treatment called CNTY-101 for people with severe autoimmune diseases like lupus, scleroderma, and inflammatory myopathies that haven't responded to standard therapies. CNTY-101 uses specially engineered immune cells to target and destroy faulty …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:09 UTC
-
Engineered immune cells take on lupus and other autoimmune diseases
Disease control TerminatedThis early-stage study tests a new treatment called RD06-04, which uses a patient's own immune cells modified to target and destroy faulty B cells. It aims to control active autoimmune diseases like lupus, scleroderma, and Sjögren's syndrome. The main goal is to check safety, but…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
Immune system reset: CAR T-Cells take on autoimmune diseases
Disease control OngoingThis early-phase study tests a one-time treatment called KYV-101, which uses a patient's own modified immune cells to target and destroy faulty B cells driving autoimmune diseases like lupus, vasculitis, and scleroderma. Up to 24 adults will receive the therapy and be monitored f…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: David Porter • Aim: Disease control
Last updated May 26, 2026 04:05 UTC
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called Prula-cel for people with certain autoimmune diseases like lupus and scleroderma. Prula-cel uses specially engineered immune cells from a healthy donor to target and attack faulty immune cells that cause disease. The main goals …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Can the shingles vaccine protect vulnerable patients?
Prevention OngoingThis study looks at whether the Shingrix vaccine is safe and effective for people with autoimmune rheumatic diseases like rheumatoid arthritis and lupus, who have a higher risk of shingles. About 2,000 participants will receive the vaccine or no vaccine, and researchers will moni…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated May 26, 2026 03:52 UTC